HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histological, biochemical, and genetic characterization of early-onset fulminating sialidosis type 2 in a Korean neonate with hydrops fetalis.

Abstract
Non-immune hydrops fetalis is the most severe presenting feature of lysosomal storage disorders. However, it is difficult to identify the underlying condition because the different lysosomal storage diseases share many clinical features. A neonate with hydrops fetalis is described here. A lysosomal storage disorder was first suspected when the placental biopsy showed the presence of macrophages containing numerous cytoplasmic vacuoles. Subsequent comprehensive diagnostic processes and biochemical and molecular genetics characterization revealed a rare genetic cause, namely sialidosis type 2. Liquid chromatography-mass spectrometry revealed increased amounts of bound sialic acid in the urine. Pathogenic NEU1 mutations were detected. This is the first case with sialidosis type 2 ever known in the Korean population, exhibiting its most severe manifestation.
AuthorsBeom Hee Lee, Yoo-Mi Kim, Joo Hyun Kim, Gu-Hwan Kim, Byong Sop Lee, Chong Jai Kim, Hyun Ju Yoo, Han-Wook Yoo
JournalBrain & development (Brain Dev) Vol. 36 Issue 2 Pg. 171-5 (Feb 2014) ISSN: 1872-7131 [Electronic] Netherlands
PMID23433491 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Topics
  • Genetic Predisposition to Disease
  • Humans
  • Hydrops Fetalis (diagnosis, etiology, genetics, pathology)
  • Infant, Newborn
  • Lysosomal Storage Diseases (diagnosis, etiology, genetics, pathology)
  • Mucolipidoses (complications, genetics)
  • Mutation (genetics)
  • Republic of Korea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: